| 0 (0%) | 02-21 12:57 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 302.92 | 1-year : | 328.54 |
| Resists | First : | 259.34 | Second : | 281.29 |
| Pivot price | 241.75 |
|||
| Supports | First : | 223.85 | Second : | 186.24 |
| MAs | MA(5) : | 245.37 |
MA(20) : | 240.64 |
| MA(100) : | 265.92 |
MA(250) : | 242.78 |
|
| MACD | MACD : | -3.8 |
Signal : | -5.3 |
| %K %D | K(14,3) : | 57 |
D(3) : | 60.3 |
| RSI | RSI(14): 44.5 |
|||
| 52-week | High : | 321.78 | Low : | 186.77 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ WST ] has closed above bottom band by 47.5%. Bollinger Bands are 16.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 245.65 - 247.19 | 247.19 - 248.27 |
| Low: | 235.63 - 237.54 | 237.54 - 238.89 |
| Close: | 238.61 - 241.41 | 241.41 - 243.39 |
Fri, 20 Feb 2026
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth - Yahoo Finance
Fri, 20 Feb 2026
Vanguard Group Inc. Buys 388,144 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Fri, 20 Feb 2026
West Pharmaceutical Services, Inc. $WST Shares Sold by ICICI Prudential Asset Management Co Ltd - MarketBeat
Thu, 19 Feb 2026
Trump Tops Williams In Cracker - World Snooker Tour
Thu, 19 Feb 2026
Assessing West Pharmaceutical Services (WST) Valuation After New US$1b Buyback And Earnings Update - simplywall.st
Wed, 18 Feb 2026
Assessing West Pharmaceutical Services (WST) Valuation After Earnings Beat Guidance And US$1b Buyback Announcement - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 72 (M) |
| Shares Float | 71 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 97.7 (%) |
| Shares Short | 1,920 (K) |
| Shares Short P.Month | 2,060 (K) |
| EPS | 6.69 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 42.43 |
| Profit Margin | 16.2 % |
| Operating Margin | 21.8 % |
| Return on Assets (ttm) | 10.2 % |
| Return on Equity (ttm) | 16.9 % |
| Qtrly Rev. Growth | 7.6 % |
| Gross Profit (p.s.) | 14.87 |
| Sales Per Share | 41.97 |
| EBITDA (p.s.) | 11.13 |
| Qtrly Earnings Growth | 3.7 % |
| Operating Cash Flow | 694 (M) |
| Levered Free Cash Flow | 251 (M) |
| PE Ratio | 35.98 |
| PEG Ratio | 0 |
| Price to Book value | 5.68 |
| Price to Sales | 5.74 |
| Price to Cash Flow | 25 |
| Dividend | 0.21 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|